Clinical Trials Directory

Trials / Completed

CompletedNCT03232359

Immature Platelet Fraction as a Promising Biomarker in Prediction Outcome of HELLP Syndrome

Assessment of Immature Platelet Fraction in Pregnancy-Associated Thrombotic Microangiopathy

Status
Completed
Phase
Study type
Observational
Enrollment
57 (actual)
Sponsor
AYMAN ABDELKADER MOHAMED ABDELKADER · Academic / Other
Sex
Female
Age
20 Years
Healthy volunteers
Accepted

Summary

Immature platelet fraction is a non-invasive test of real time thrombopoiesis. High IPF% has been suggested as an indicator of thrombocytopenia due to rapid platelet consumption. IPF% is able to discriminate between patients with TTP/HUS or SPE/HELLP

Detailed description

Thrombotic microangiopathy (TMA) syndromes are extraordinarily diverse. Thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS) are the two most well known, and are considered to be the most serious. TTP-HUS occurs more commonly in women and among women is commonly associated with pregnancy. Nevertheless, there are other pregnancy conditions that may manifest with TMA, including preeclampsia, eclampsia, HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count), in addition to acute fatty liver of pregnancy, antiphospholipid syndrome, and systemic lupus erythematosis. Assessment of immature platelets was introduced as a non-invasive test of real time thrombopoiesis. They are newly released in the circulation with a larger size \& greater RNA content than mature platelets, and can be measured by automated haematology analyzer equipped with reticulocyte detection channel and described as immature platelet fraction (%-IPF) and immature platelet count (A-IPC). A high %-IPF has been suggested as an indicator of thrombocytopenia due to rapid platelet consumption, while a low %-IPF is characteristic of bone marrow suppression states. %-IPF/A-IPF has the competency to be performed routinely and, therefore, can provide therapeutic and diagnostic feedback in the life threatening conditions. The present study aimed to show the utility of estimating %-IPF and A-IPC using a reticulocyte detection channel CBC autoanalyzer as a simple reproducible blood analysis to be employed in the differential diagnosis of pregnancy-associated thrombotic microangiopathic conditions.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTimmature platelets fractionIPF-% and A-IPC using a reticulocyte detection channel CBC auto analyzer

Timeline

Start date
2015-01-01
Primary completion
2015-12-01
Completion
2016-06-01
First posted
2017-07-28
Last updated
2017-07-28

Source: ClinicalTrials.gov record NCT03232359. Inclusion in this directory is not an endorsement.